Search Results 21-30 of 11127 for fsa eligible

  1. Study Of Cabozantinib Alone Or In Combination With Atezolizumab To Subjects With Locally Advanced Or Metastatic Solid Tumors - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  2. A Study To Evaluate Androgen-Deprivation Therapy And Radiation Therapy In Treating Patients With Prostate Cancer - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  3. Flu shot: Your best bet for avoiding influenza - Mayo Clinic

    The nasal spray vaccine is approved for people between 2 and 49 years old. The nasal flu vaccine isn't recommended for some people, including: People who ...

  4. Eligibility

    Eligibility. Print. People with heart failure who haven't been successfully treated with other options may be candidates for heart transplant at Mayo Clinic ...

  5. A Study Of A New Way To Treat Children And Young Adults With A Brain Tumor Called NGGCT - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  6. Evaluation Of The Efficacy And Safety Of ALV003 In Symptomatic In Celiac Disease Patients - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  7. Definition of terms - Mayo Clinic Research

    The FDA considers an investigation of a nonsignificant risk device to have an approved IDE when an IRB concurs with the initial nonsignificant risk ...

  8. Physician Health Center - Frequently asked questions - Mayo Clinic

    Who is eligible to participate? The Mayo Clinic Physician Health Center is available to practicing physicians including those who are temporarily restricted ...

  9. Pembrolizumab, Lenalidomide, And Dexamethasone In Treating Patients With Newly Diagnosed Multiple Myeloma Eligible For Stem Cell Transplant - Mayo Clinic

    Clinical Trials · Pembrolizumab, Lenalidomide, And Dexamethasone In Treating Patients With Newly Diagnosed Multiple Myeloma Eligible For Stem Cell Transplant.

  10. A Study of the SynCardia Temporary Total Artificial Heart Used as End Point Therapy - Mayo Clinic

    ... eligible for transplantation. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...